Nicole R. Hadas, CLO of Akebia Therapeutics AKBA, has filed 0 purchases and 8 sales on the open market. The latest trade was on 24/05/13.

NH

NH

Nicole R. Hadas

SVP, Chief Legal Officer

Company

Akebia Therapeutics AKBA

First filing

23/03/03

Trades

13 trades

Buys / sales

0 / 8

12-month net buying

No record

Last trade

24/05/13

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	24/05/13	24/05/14	12,016 sh	$1.26	$15,140.16	−1.8%
Akebia TherapeuticsAKBA	Open-market sale	24/02/29	24/03/01	5,974 sh	$1.58	$9,438.92	−0.9%
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	24/02/27	24/02/29	7,411 sh	$1.52	$11,264.72	−1.1%
Akebia TherapeuticsAKBA	Open-market sale	23/05/25	23/05/25	63,186 sh	$1.22	$77,086.92	−10.8%
Akebia TherapeuticsAKBA	Open-market sale	23/03/01	23/03/03	13,034 sh3 trades	$0.88avg.	$11,469.92	−4.3%
Akebia TherapeuticsAKBA	Open-market sale	23/02/27	23/03/01	6,677 sh	$0.81	$5,408.37	−2.2%